EGFR and breast cancer: Thomas et al. (2019) conjugated [111In]In-DTPA-EGF to liposomes (140 nm; zeta potential = − 30 mV) that also incorporated doxorubicin for combined chemoradiotherapy of EGFR-overexpressing BC.